➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

Hetero Labs Ltd V Company Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD V, and what generic and branded alternatives to HETERO LABS LTD V drugs are available?

HETERO LABS LTD V has twenty-five approved drugs.

There are four tentative approvals on HETERO LABS LTD V drugs.

Summary for Hetero Labs Ltd V
US Patents:0

Drugs and US Patents for Hetero Labs Ltd V

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd V VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride TABLET;ORAL 203047-001 Apr 8, 2015 AB RX No No   Start Trial   Start Trial
Hetero Labs Ltd V LAMIVUDINE lamivudine TABLET;ORAL 203277-001 Jan 6, 2014 AB RX No No   Start Trial   Start Trial
Hetero Labs Ltd V PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 202882-002 Sep 10, 2014 AB RX No No   Start Trial   Start Trial
Hetero Labs Ltd V LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 203835-003 Aug 12, 2015 AB RX No No   Start Trial   Start Trial
Hetero Labs Ltd V FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 204097-002 Aug 19, 2016 OTC No No   Start Trial   Start Trial
Hetero Labs Ltd V ARIPIPRAZOLE aripiprazole TABLET;ORAL 205064-001 Apr 28, 2015 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.